ADVANCES IN ACTIVE AND PASSIVE IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE

被引：0
|
作者：
Hock, Christoph [1 ]
Grimm, Jan [2 ]
Sevigny, Jeff [3 ]
Nitsch, Roger M. [1 ]
机构：
[1] Univ Zurich, Div Psychiat Res, CH-8006 Zurich, Switzerland
[2] Neurimmune Therapeut, Schlieren, Switzerland
[3] Biogen Idec Inc, Cambridge, MA USA
来源：
NEUROBIOLOGY OF AGING | 2014年 / 35卷
关键词：
D O I：
10.1016/j.neurobiolaging.2014.01.067
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [41] Immunology and immunotherapy of Alzheimer's disease
    Howard L. Weiner
    Dan Frenkel
    Nature Reviews Immunology, 2006, 6 : 404 - 416
  • [42] Immunotherapy as a treatment for Alzheimer's disease
    Lemere, C. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S172 - S172
  • [43] Tau immunotherapy for Alzheimer's disease
    Pedersen, Jan Torleif
    Sigurdsson, Einar M.
    TRENDS IN MOLECULAR MEDICINE, 2015, 21 (06) : 394 - 402
  • [44] Safety and efficacy of active and passive immunotherapy in mild-to-moderate Alzheimer's disease: A systematic review and network meta-analysis
    Foroutan, Naghmeh
    Hopkins, Robert B.
    Tarride, Jean-Eric
    Florez, Ivan D.
    Levine, Mitchell
    CLINICAL AND INVESTIGATIVE MEDICINE, 2019, 42 (01): : E53 - E65
  • [45] Active DNA Aβ42 vaccination as immunotherapy for alzheimer disease
    Lambracht-Washington, Doris
    Rosenberg, Roger N.
    TRANSLATIONAL NEUROSCIENCE, 2012, 3 (04) : 307 - 313
  • [46] PASSIVE IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE: WHAT HAVE WE LEARNED, AND WHERE ARE WE HEADED?
    Aisen, P. S.
    Vellas, B.
    JOURNAL OF NUTRITION HEALTH & AGING, 2013, 17 (01): : 49 - 50
  • [47] Promising Results from Alzheimer's Disease Passive Immunotherapy Support the Development of a Preventive Vaccine
    Marciani, D. J.
    RESEARCH, 2019, 2019
  • [48] Passive immunotherapy for Alzheimer’s disease: What have we learned, and where are we headed?
    P. S. Aisen
    B. Vellas
    The journal of nutrition, health & aging, 2013, 17 : 49 - 50
  • [49] Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
    Moreth, Jens
    Mavoungou, Chrystelle
    Schindowski, Katharina
    IMMUNITY & AGEING, 2013, 10
  • [50] Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
    Jens Moreth
    Chrystelle Mavoungou
    Katharina Schindowski
    Immunity & Ageing, 10
12345